US FDA Tries To Shape The Accelerated Approval Reform Narrative

 
• By Derrick Gingery
  
uncertainty
Industry and patient advocates also argue in favor of accelerated approval's ability to provide earlier access to drugs for diseases with unmet needs. • Source: Alamy

More from Review Pathways

More from Pathways & Standards